Home/Filings/4/0001181431-12-012615
4//SEC Filing

Stanley Michael D 4

Accession 0001181431-12-012615

CIK 0000893949other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 5:00 PM ET

Size

13.2 KB

Accession

0001181431-12-012615

Insider Transaction Report

Form 4
Period: 2012-02-24
Stanley Michael D
President, Pediatrix Division
Transactions
  • Exercise/Conversion

    Common Stock

    2012-02-24$55.43/sh+9,800$543,21430,525 total
  • Sale

    Common Stock

    2012-02-24$75.45/sh9,800$739,43520,725 total
  • Exercise/Conversion

    Common Stock

    2012-02-27$55.43/sh+4,053$224,65824,778 total
  • Sale

    Common Stock

    2012-02-27$75.50/sh4,053$306,00020,725 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2012-02-24$55.43/sh9,800$543,2144,053 total
    Exercise: $55.43From: 2011-06-01Exp: 2018-06-02Common Stock (9,800 underlying)
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2012-02-27$55.43/sh4,053$224,6580 total
    Exercise: $55.43From: 2011-06-01Exp: 2018-06-02Common Stock (4,053 underlying)
Footnotes (3)
  • [F1]Sales of shares were made pursuant to Reporting Person's 10b5-1 trading plan.
  • [F2]Sales of shares were executed in eighteen (18) separate transactions with prices ranging from $75.43 to $75.59 for a weighted average sales price of $75.4526.
  • [F3]Sales of shares were executed in eighteen (18) separate transactions with prices ranging from $75.43 to $75.63 for a weighted average sales price of $75.4997.

Issuer

MEDNAX, INC.

CIK 0000893949

Entity typeother

Related Parties

1
  • filerCIK 0001542492

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:00 PM ET
Size
13.2 KB